Bitolterol is a beta-2-adrenergic receptor agonist and prodrug used to treat bronchospasms associated with asthma and chronic obstructive pulmonary disease, functioning by releasing the active metabolite… Read more
Bitolterol is a beta-2-adrenergic receptor agonist and prodrug used to treat bronchospasms associated with asthma and chronic obstructive pulmonary disease, functioning by releasing the active metabolite colterol within the body. This category contains a comprehensive selection of reference standards, including the parent drug, its mesylate salt, and critical process-related impurities such as N-tert-butylmetarterenol and the 1-oxo derivative of colterol. These high-quality compounds are essential for laboratories conducting rigorous impurity profiling, method validation, and pharmaceutical quality control. Additionally, stable isotope labelled compounds, including deuterated versions of colterol and its methylated metabolites, are available to serve as precise internal standards for mass spectrometry and other analytical techniques, ensuring accurate quantification and consistent monitoring of this therapeutic agent throughout its development and manufacturing lifecycle.